Hydralazine-induced lupus: Maintaining vigilance with increased use in patients with heart failure

Southern Medical Journal

Volumn 99, Issue 1, 2006, Pages 18-22

  Finks, Shannon W ^a,b   Finks, A Lloyd ^a   Self, Timothy H ^a  

^a METHODIST UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Drug induced lupus; Hydralazine; Hydralazine induced lupus

Indexed keywords

HLA DR4 ANTIGEN; HYDRALAZINE; VASODILATOR AGENT;

ANEMIA; ARTHRALGIA; ARTHRITIS; AUTOIMMUNE DISEASE; CONGESTIVE HEART FAILURE; DISEASE DURATION; DRUG MEGADOSE; FAMILY HISTORY; FATIGUE; FEVER; HUMAN; KIDNEY FAILURE; LEUKOPENIA; LUNG EDEMA; PATIENT MONITORING; PHENOTYPE; REVIEW; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX PAIN; THROMBOCYTOPENIA; WEIGHT REDUCTION; CHEMICALLY INDUCED DISORDER; SEX DIFFERENCE;

HEART FAILURE, CONGESTIVE; HUMANS; HYDRALAZINE; LUPUS ERYTHEMATOSUS, SYSTEMIC; RISK FACTORS; SEX FACTORS; VASODILATOR AGENTS;

EID: 33644870797     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.smj.0000197121.12352.19     Document Type: Review

References (27)

1. Lee SL, Chase PH. Drug induced systemic lupus erythematosus: a critical review. Semin Arthritis Rheum 1975;5:83-85.
2. Morrow JD, Schroeder HA, Perry HM Jr. Studies on the control of hypertension by hyphex, II: Toxic reactions and side effects. Circulation 1953;8:829-839.
3. Alarcon-Segovia D. Drug induced lupus syndromes. Mayo Clin Proc 1969;44:664-681.
4. Skaer TL. Medication induced systemic lupus erythematosus. Clin Ther 1992;14:496-506.
5. Cameron HA, Ramsey LE. The lupus syndrome induced by hydralazine: A common complication with low dose treatment. Br Med J 1984;289: 410-412.
6. Innes A, Rennie JA, Cato GR. Drug induced lupus caused by very low dose hydralazine. Br J Rheumatol 1986;25:225.
7. Yonga GO. Re: Low dose hydralazine induced lupus. East Afr Med J 1992;69:649-650.
8. Ramsey-Goldman FT, Solano FX, Medsger TA. Hydralazine induced lupus and sweet's syndrome report and review of the literature. J Rheumatol 1990;682-684.
9. Stratton MA. Drug-induced systemic lupus erythematosus. Clin Pharm 1985;4:657-662.
10. Sturman SG, Kumarraratine D, Beevers DG. Fatal hydralazine-induced systemic lupus erythematosus. Lancet 1988;3:1304.
11. Kincaid-Smith P. Hydralazine: Is there a safe dose? Med J Aust 1985; 142:337.
12. Hosie J, Hosie GAC. The lupus syndrome induced by hydralazine. Br Med J 1984;289:923.
13. Bass BH. Hydralazine lung. Thorax 1981;36:695-696.
14. Weinstein J. Hypocomplementemia in hydralazine-associated systemic lupus erythematosus. Am J Med 1978;65:553-556.
15. Peipho RW, Beal J. An overview of antihypertensive therapy in the 20th century. J Clin Pharmacol 2000;40:967-977.
16. Taylor AL, Ziesche S, Yancy C, et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 2004; 351:2049-2057.
17. Koch-Weser J. Vasodilator drugs in the treatment of hypertension. Arch Intern Med 1974;133:1020-1021.
18. Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. N Engl J Med 1986; 314:1547-1552.
19. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of congestive heart failure. N Engl J Med 1991;325:1667-1675.
20. Mansilla-Tinoco R, Harland SJ, Ryan PJ, et al. Hydralazine, antinuclear antibodies, and the lupus syndrome. Br Med J 1982;284:936-939.
21. Olsen NJ. Drug-induced autoimmunity. Best Pract Res Clin Rheumatol 2004;18:677-688.
22. Perry HM Jr, Tane EM, Carmody S, et al. Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients treated with hydralazine. J Lab Clin Med 1970;76:114-125.
23. Out of Drug Induced Systemic Lupus Erythematosus: A critical review. Seminars in arthritis and rheumatism, vol 5, No. 1 (August 1975).
24. Taylor AL, Cohn J. Isosorbide dinitrate and hydralazine in blacks with heart failure: Correspondence. N Engl J Med 2005;352:1043.
25. Batchelor JR, Welsh KI, Tinoco RM. Hydralazine-induced systemic lupus erythematosus: Influence of HLA-DR and sex on susceptibility. Lancet 1980;1:1107-1109.
26. Antonov D, Kazandjieva J, Etugov D, et al. Drug-induced lupus erythematosus. Clin Dermatol 2004;22:157-166.
27. Harland SJ, Faccini V, Timbrell JA. Hydralazine-induced lupus erythematosus-like syndrome in a patient of the rapid acetylator phenotype. Br Med J 1980;2:273-274.